IGC Pharma Inc (IGC)
0.3705
+0.01
(+2.35%)
USD |
NYAM |
Oct 04, 16:00
0.3622
-0.01
(-2.24%)
After-Hours: 20:00
IGC Pharma Net Income (Annual): -13.00M for March 31, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| March 31, 2024 | -13.00M |
| March 31, 2023 | -11.51M |
| March 31, 2022 | -15.02M |
| March 31, 2021 | -8.811M |
| March 31, 2020 | -7.315M |
| March 31, 2019 | -4.097M |
| March 31, 2018 | -1.786M |
| March 31, 2017 | -1.867M |
| March 31, 2016 | -2.808M |
| March 31, 2015 | -4.614M |
| Date | Value |
|---|---|
| March 31, 2014 | -3.023M |
| March 31, 2013 | -2.252M |
| March 31, 2012 | -7.752M |
| March 31, 2011 | -20.24M |
| March 31, 2010 | -4.789M |
| March 31, 2009 | -0.5216M |
| March 31, 2008 | -5.215M |
| March 31, 2007 | 1.518M |
| March 31, 2006 | -0.4438M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-15.02M
Minimum
2022
-7.315M
Maximum
2020
-11.13M
Average
-11.51M
Median
2023
Net Income (Annual) Benchmarks
| CEL-SCI Corp | -32.19M |
| AIM ImmunoTech Inc | -28.96M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Protalix BioTherapeutics Inc | 8.312M |
| Palatin Technologies Inc | -29.74M |